Advances in polycystic ovary syndrome treatment: metformin and ovarian diathermy.

Catherine Leclair, Phillip E. Patton

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Polycystic ovary syndrome (PCOS) affects approximately 6% of women in their reproductive years. The symptoms of the syndrome are chronic anovulation and androgen excess. Infertility due to ovulatory dysfunction is a common problem for women with PCOS. Metformin, an antihyperglycemic agent, can correct the metabolic dysfunction that occurs with PCOS, and also stimulate folliculogenesis. The drug is effective alone and in combination with clomiphene citrate. An alternative option, ovarian diathermy, also promotes ovulation through changes in the intraovarian hormonal environment. Both techniques provide promising and effective alternatives for women with PCOS who do not respond to traditional oral ovulation induction agents.

Original languageEnglish (US)
Pages (from-to)333-337
Number of pages5
JournalCurrent women's health reports
Issue number5
StatePublished - Oct 2002

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Advances in polycystic ovary syndrome treatment: metformin and ovarian diathermy.'. Together they form a unique fingerprint.

Cite this